Bio-Rad Laboratories, Inc. Class A is a company in the U.S. stock market and it is a holding in 176 U.S.-traded ETFs. BIO has around 2.3M shares in the U.S. ETF market. The largest ETF holder of BIO is the SPDR S&P 500 ETF Trust (SPY), with approximately 221.08K shares. Investors may also find of interest that the ETF with the largest allocation to BIO stock is ETFMG Treatments Testing and Advancements ETF (GERM), with a portfolio weight of 6.68%. On average, U.S. ETFs allocate 0.32% of BIO to their portfolios.
Additionally, BIO is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BIO as a holding is the ProShares UltraPro S&P500 (UPRO), with a return of 122.65%.